3p and 10q deletions detected by fluorescence in situ hybridization (FISH): A potential new tool for early detection of non-small cell lung cancer (NSCLC)

7606 Objectives: To study the feasibility of detecting chromosomal deletions at the 3p and 10q regions in bronchoscopic brush biopsies and touch preparations by FISH and to study their distribution...

[1]  M. Spitz,et al.  Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer , 2008, Modern Pathology.

[2]  C. Henschke.  CT screening for lung cancer is justified , 2007, Nature Clinical Practice Oncology.

[3]  N. Altorki,et al.  Long-term survival and recurrence in patients with resected non-small cell lung cancer 1 cm or less in size. , 2006, The Journal of thoracic and cardiovascular surgery.

[4]  J. Jett,et al.  A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. , 2006, Chest.

[5]  L. Bubendorf,et al.  Multitarget fluorescence in situ hybridization elucidates equivocal lung cytology. , 2006, Chest.

[6]  Feng Jiang,et al.  Surfactant Protein A Gene Deletion and Prognostics for Patients with Stage I Non–Small Cell Lung Cancer , 2005, Clinical Cancer Research.

[7]  R. Morice,et al.  Comparison of molecular abnormalities in bronchial brushings and tumor touch preparations , 2004, Cancer.

[8]  J. Minna,et al.  Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo , 2004, Cancer Gene Therapy.

[9]  M. Goto,et al.  Combined status of MUC1 mucin and surfactant apoprotein A expression can predict the outcome of patients with small‐size lung adenocarcinoma , 2004, Histopathology.

[10]  T. Petty.  Sputum cytology for the detection of early lung cancer. , 2003, Current opinion in pulmonary medicine.

[11]  Y. Miller,et al.  Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. , 2003, The Journal of molecular diagnostics : JMD.

[12]  F. Hirsch,et al.  Molecular approaches to lung cancer evaluation. , 2002, Lung cancer.

[13]  J. Minna,et al.  Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers , 2002, Oncogene.

[14]  Feng Jiang,et al.  Use of Interphase Fluorescence In Situ Hybridization as a Powerful Diagnostic Tool in Cytology , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[15]  Y. Pekarsky,et al.  FHIT as Tumor Suppressor: Mechanisms and Therapeutic Opportunities , 2002, Cancer biology & therapy.

[16]  A Coldman,et al.  Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. , 1998, Chest.

[17]  A. Gazdar,et al.  Differential effects of glucocorticoid on expression of surfactant proteins in a human lung adenocarcinoma cell line. , 1988, Biochimica et biophysica acta.

[18]  S. Latt,et al.  The 35 kd pulmonary surfactant-associated protein is encoded on chromosome 10 , 1987, Human Genetics.

[19]  R. Fontana,et al.  Some results of screening for early lung cancer , 1981, Cancer.

[20]  T. Byers,et al.  Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. , 2004, Cancer Detection and Prevention.